Journal
INTERNATIONAL JOURNAL OF ONCOLOGY
Volume 59, Issue 4, Pages -Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ijo.2021.5256
Keywords
pancreatic carcinoma; cancer stem cell; voltage-gated potassium channel; 4-aminopyridine
Categories
Funding
- Japan Society for the Promotion of Science [17K10602, 17K10710, 18K08628, 18K08689, 19K09202, 19K09182, 19K18160]
- Grants-in-Aid for Scientific Research [18K08628, 18K08689, 17K10602, 17K10710, 19K09202, 19K09182, 19K18160] Funding Source: KAKEN
Ask authors/readers for more resources
The study identified the higher expression of ALDH1A1 in pancreatic cancer stem cells (PCSCs), along with their resistance to 5-fluorouracil and redifferentiation capacity. Additionally, the upregulation of ion channel gene expression, including voltage-gated potassium channels (Kv), was observed in PCSCs, and the Kv inhibitor 4-AP showed greater cytotoxicity in PCSCs compared to non-PCSCs.
The targeting of membrane proteins that are activated in cancer stem cells (CSCs) represents one of the key recent strategies in cancer therapy. The present study analyzed ion channel expression profiles and functions in pancreatic CSCs (PCSCs). Cells strongly expressing aldehyde dehydrogenase 1 family member A1 (ALDH1A1) were isolated from the human pancreatic PK59 cell line using fluorescence-activated cell sorting, and PCSCs were identified based on tumorsphere formation. Microarray analysis was performed to investigate the gene expression profiles in PCSCs. ALDH1A1 messenger RNA levels were higher in PCSCs compared with non-PCSCs. PCSCs were resistant to 5-fluorouracil and capable of redifferentiation. The results of the microarray analysis revealed that gene expression related to ion channels, including voltage-gated potassium channels (Kv), was upregulated in PCSCs compared with non-PCSCs. 4-Aminopyridine (4-AP), a potent Kv inhibitor, exhibited greater cytotoxicity in PCSCs compared with non-PCSCs. In a xenograft model in nude mice, tumor volumes were significantly lower in mice inoculated with PK59 cells pre-treated with 4-AP compared with those in mice injected with non-treated cells. The present results identified a role of Kv in the persistence of PCSCs and suggested that the Kv inhibitor 4-AP may have potential as a therapeutic agent for pancreatic carcinoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available